Mehdi Benzaoui Postdoctoral Associate in Pharmacology

Postdoctoral Associate in Pharmacology, Pharmacology , Weill Cornell Medical College 2023 -

Publications

Sort by

Co-Author Network

Metabolic dialogues: regulators of chimeric antigen receptor T cell function in the tumor microenvironment. Molecular oncology. 2024 Review GET IT
Manufacture of CD22 CAR T cells following positive versus negative selection results in distinct cytokine secretion profiles and γδ T cell output. Molecular therapy. Methods & clinical development. 2023 Academic Article GET IT
An optimized bicistronic chimeric antigen receptor against GPC2 or CD276 overcomes heterogeneous expression in neuroblastoma. The Journal of clinical investigation. 2022 Academic Article GET IT
Times cited: 46
CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR. Blood. 2022 Academic Article GET IT
Times cited: 97
A SNIPpet of safety: a Goldilocks approach in CAR-T therapy. Cell research. 2022 Comment GET IT
Clinical and Product Features Associated with Outcome of DLBCL Patients to CD19-Targeted CAR T-Cell Therapy. Cancers. 2021 Academic Article GET IT
Times cited: 19

Sort by

Co-investigator Network

Targeting tumor and T-cell metabolism to bridge the gap in CAR-T efficacy between liquid and solid tumors awarded by Parker Institute for Cancer Immunotherapy Principal Investigator 2025 - 2026

Targeting immune evasion in gastroesophageal cancer awarded by National Institute of Diabetes & Digestive & Kidney Diseases Key Personnel 2023 - 2026